New Zealand markets open in 8 hours 14 minutes

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
127.000.00 (0.00%)
As of 09:30AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 567.03B
Enterprise value 569.57B
Trailing P/E 44.19
Forward P/E 37.88
PEG ratio (5-yr expected) 2.26
Price/sales (ttm)16.15
Price/book (mrq)39.62
Enterprise value/revenue 2.33
Enterprise value/EBITDA 4.59

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 351.57%
S&P500 52-week change 325.59%
52-week high 3140.32
52-week low 374.70
50-day moving average 3126.86
200-day moving average 3106.62

Share statistics

Avg vol (3-month) 329.39k
Avg vol (10-day) 319.35k
Shares outstanding 53.38B
Implied shares outstanding 64.46B
Float 83.19B
% held by insiders 16.06%
% held by institutions 137.58%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 41.86
Forward annual dividend yield 41.46%
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 41.42
Payout ratio 447.21%
Dividend date 320 Aug 2019
Ex-dividend date 422 Mar 2024
Last split factor 22:1
Last split date 313 Sept 2023

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 36.55%
Operating margin (ttm)48.73%

Management effectiveness

Return on assets (ttm)25.24%
Return on equity (ttm)99.87%

Income statement

Revenue (ttm)244.24B
Revenue per share (ttm)54.60
Quarterly revenue growth (yoy)22.50%
Gross profit (ttm)N/A
EBITDA 117.85B
Net income avi to common (ttm)89.28B
Diluted EPS (ttm)2.87
Quarterly earnings growth (yoy)28.20%

Balance sheet

Total cash (mrq)9.3B
Total cash per share (mrq)2.09
Total debt (mrq)26.93B
Total debt/equity (mrq)27.22%
Current ratio (mrq)0.70
Book value per share (mrq)22.18

Cash flow statement

Operating cash flow (ttm)93.41B
Levered free cash flow (ttm)40.24B